Rare Patient Voice has been acquired by Konovo

January 2026 — Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Rare Patient Voice empowers patients and family caregivers to have their voices heard through participation in research, including market research, health economics, outcomes research, real-world evidence studies, user experience, human factors research and clinical trials. Its community includes over 200,000 patients and caregivers spanning more than 1,500 diseases, both rare and non-rare, across nine countries. By fostering trusted relationships and delivering high-quality insights, Rare Patient Voice enables research that reflects real-world patient experiences.

Konovo is a global healthcare company on a mission to transform research through technology and connected insights. It simplifies the research process, connects fragmented insights and enhances access to healthcare audiences including physicians, patients, caregivers and allied healthcare professionals through its intelligent platform and expert-guided solutions. Operating across the Americas, Europe and Asia, Konovo supports market research agencies, consultancies and life science and healthcare brands with deep, actionable insights.

Our role in the transaction

Oaklins DeSilva+Phillips, based in New York, served as the exclusive financial advisor to Rare Patient Voice in this transaction, highlighting its deep sector expertise in advising healthcare technology businesses, particularly within the insights and analytics industry.